TY - BOOK AU - Bhimraj, A. AU - Morgan, R. L. AU - Shumaker, A. H. AU - Lavergne, V. AU - Baden, L. AU - Cheng, V. C. PY - 2020 DA - 2020// TI - Infectious diseases Society of America guidelines on the treatment and management of patients with COVID-19 ID - Bhimraj2020 ER - TY - STD TI - Pan H, Peto R, Karim QA, Alejandria M, Henao-Restrepo AM, Garcia CH, et al. Repurposed antiviral drugs for COVID-19 -interim WHO SOLIDARITY trial results. medRxiv. 2020. https://doi.org/10.1101/2020.10.15.20209817. ID - ref2 ER - TY - STD TI - New Jersey COVID-19 Information Hub. https://covid19.nj.gov/. Accessed 18 June 2020. UR - https://covid19.nj.gov/ ID - ref3 ER - TY - STD TI - Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html. Accessed 27 Nov 2020. UR - https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html ID - ref4 ER - TY - STD TI - Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020. https://doi.org/10.1016/j.ijantimicag.2020.105949 [published online ahead of print, 2020 Mar 20]. ID - ref5 ER - TY - STD TI - Ip A, Berry DA, Hansen E, Goy AH, Pecora AL, Sinclaire BA, et al. Hydroxychloroquine and tocilizumab therapy in COVID-19 patients - an observational study. PLoS One. 2020. https://doi.org/10.1371/journal.pone.0237693. ID - ref6 ER - TY - STD TI - Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2012410. ID - ref7 ER - TY - STD TI - Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, et al. Association of Treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state. JAMA. 2020. https://doi.org/10.1001/jama.2020.8630 [published online ahead of print, 2020 May 11]. ID - ref8 ER - TY - STD TI - Mahévas M, Tran VT, Roumier M, Chabrol A, Paule R, Guillaud C, et al. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. BMJ. 2020. https://doi.org/10.1136/bmj.m1844 [published correction appears in BMJ. 2020 Jun 18;369:m2328]. ID - ref9 ER - TY - STD TI - Arshad S, Kilgore P, Chaudhry ZS, Jacobsen G, Wang DD, Huitsing K, et al. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. Int J Infect Dis. 2020. https://doi.org/10.1016/j.ijid.2020.06.099. ID - ref10 ER - TY - STD TI - Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2016638 [published online ahead of print, 2020 Jun 3]. ID - ref11 ER - TY - STD TI - Mitja O, Corbacho-Monné M, Ubals M, Tebe C, Penafiel J, Tobias A, et al. Hydroxychloroquine for early treatment of adults with mild Covid-19: a randomized-controlled trial. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa1009. ID - ref12 ER - TY - STD TI - Skipper CP, Pastick KA, Engen NW, Bangdiwala AS, Abassi M, Lofgren SM, et al. Hydroxychloroquine in non-hospitalized adults with early COVID-19: a randomized trial. Ann Intern Med. 2020. https://doi.org/10.7326/M20-4207. ID - ref13 ER - TY - STD TI - Esper RB, da Silva RS, Oikawa FTC, Castro MM, Razuk-Filho A, Batista PB, et al. Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine. https://pgibertie.files.wordpress.com/2020/04/2020.04.15-journal-manuscript-final.pdf. Accessed 18 June 2020. UR - https://pgibertie.files.wordpress.com/2020/04/2020.04.15-journal-manuscript-final.pdf ID - ref14 ER - TY - STD TI - Guérin V, Lévy P, Thomas JL, Lardenois T, Lacrosse P, Sarrazin E, et al. Azithromycin and hydroxychloroquine accelerate recovery of outpatients with mild/moderate COVID-19. Asian J Med Health. 2020. https://doi.org/10.9734/ajmah/2020/v18i730224. ID - ref15 ER - TY - STD TI - Scholz M, Derwand R, Zelenko V. COVID-19 outpatients – early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study. Int J Antimicrob Agents. 2020. https://doi.org/10.1016/j.ijantimicag.2020.106214. ID - ref16 ER - TY - STD TI - Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-world evidence - what is it and what can it tell us? N Engl J Med. 2016. https://doi.org/10.1056/NEJMsb1609216. ID - ref17 ER - TY - STD TI - Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry Food and Drug Administration2018 https://www.fda.gov/media/97567/download. Accessed 13 July 2020. UR - https://www.fda.gov/media/97567/download ID - ref18 ER - TY - STD TI - Use of real-world evidence to support regulatory decision-making for medical devices: draft guidance for industry and Food and Drug Administration staff. 2017 https://www.fda.gov/media/120060/download. Accessed 13 July 2020. UR - https://www.fda.gov/media/120060/download ID - ref19 ER - TY - STD TI - Framework for FDA’s Real-World Evidence Program Food and Drug Administration 2018 updated December 18. Available from: https://www.fda.gov/media/120060/download. Accessed 13 July 2020. UR - https://www.fda.gov/media/120060/download ID - ref20 ER - TY - STD TI - Biran N, Ip A, Ahn J, Go RC, Wang S, Mathura S, et al. Tocilizumab among intensive care unit COVID-19 patients: a multi-center observational study. Lancet Rheumatol. 2020. https://doi.org/10.1016/S2665-9913(20)30277-0 ID - ref21 ER - TY - STD TI - Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci 2010;25(1):1–21. ID - ref22 ER - TY - JOUR AU - Ho, D. AU - Imai, K. AU - King, G. AU - Stuart, E. PY - 2007 DA - 2007// TI - Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference JO - Polit Anal VL - 15 UR - https://doi.org/10.1093/pan/mpl013 DO - 10.1093/pan/mpl013 ID - Ho2007 ER - TY - STD TI - Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Sevestre J, Mailhe M, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study. Travel Med Infect Dis. 2020. https://doi.org/10.1016/j.tmaid.2020.101663. ID - ref24 ER - TY - STD TI - Fonseca SN, Sousa AQ, Wolkof AG, Moreira MS, Pinto BC, Takeda CF, et al. Risk of hospitalization for COVID-19 outpatients treated with various drug regimens in Brazil: comparative analysis. Travel Med Infect Dis. 2020. https://doi.org/10.1016/j.tmaid.2020.101906. ID - ref25 ER - TY - STD TI - Hinton DM. Casirivimab and imdevimab EUA Letter of Authorization. https://www.fda.gov/media/143891/download. Accessed 27 Nov 2020. UR - https://www.fda.gov/media/143891/download ID - ref26 ER - TY - STD TI - Elavarasi A, Prasad M, Seth T, Sahoo RK, Madan K, Nischal N, et al. Chloroquine and Hydroxychloroquine for the treatment of COVID-19: a systematic review and meta-analysis. J Gen Intern Med. 2020. https://doi.org/10.1007/s11606-020-06146-w. ID - ref27 ER - TY - STD TI - Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020. https://doi.org/10.1016/j.ijantimicag.2020.105954. ID - ref28 ER - TY - JOUR AU - Channappanavar, R. AU - Perlman, S. PY - 2017 DA - 2017// TI - Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology JO - Semin Immunopathol VL - 39 UR - https://doi.org/10.1007/s00281-017-0629-x DO - 10.1007/s00281-017-0629-x ID - Channappanavar2017 ER - TY - JOUR AU - Huang, C. AU - Wang, Y. AU - Li, X. AU - Ren, L. AU - Zhao, J. AU - Hu, Y. PY - 2020 DA - 2020// TI - Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30183-5 DO - 10.1016/S0140-6736(20)30183-5 ID - Huang2020 ER - TY - JOUR AU - Teijaro, J. R. PY - 2017 DA - 2017// TI - Cytokine storms in infectious diseases JO - Semin Immunopathol VL - 39 UR - https://doi.org/10.1007/s00281-017-0640-2 DO - 10.1007/s00281-017-0640-2 ID - Teijaro2017 ER - TY - STD TI - Horby P, Lim WS, Emberson J, Mafham M, Bell JL, Linsell L, et al. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2021436. ID - ref32 ER - TY - STD TI - Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F, et al. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020. https://doi.org/10.1016/j.autrev.2020.102568. ID - ref33 ER - TY - STD TI - Million M, Lagierab JC, Gautret P, Colson P, Fournier PE, Amrane S, et al. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Diss. 2020. https://doi.org/10.1016/j.tmaid.2020.101738. ID - ref34 ER - TY - STD TI - Risch HA. Early outpatient treatment of symptomatic, high-risk Covid-19 patients that should be ramped-up immediately as key to the pandemic crisis. Am J Epidemiol. 2020. https://doi.org/10.1093/aje/kwaa093. ID - ref35 ER - TY - STD TI - Ladapo JA, McKinnon JE, McCullough PA, Risch H. Randomized controlled trials of early ambulatory hydroxychloroquine in the prevention of COVID-19 infection, hospitalization, and death: meta-analysis. MedRxiv. 2020. https://doi.org/10.1101/2020.09.30.20204693. ID - ref36 ER - TY - JOUR AU - Razek, A. A. K. A. AU - Badrawy, M. K. AU - Alnaghy, E. PY - 2020 DA - 2020// TI - Interstitial lung fibrosis imaging reporting and data system: what radiologist wants to know? JO - J Comput Assist Tomogr VL - 44 UR - https://doi.org/10.1097/RCT.0000000000001075 DO - 10.1097/RCT.0000000000001075 ID - Razek2020 ER - TY - STD TI - Ip A, Ahn J, Goldberg SL. Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study dataset. 2020. https://doi.org/10.7303/syn22909530 Synapse: https://www.synapse.org/#!Synapse:syn22909530/files/. UR - https://www.synapse.org/#!Synapse:syn22909530/files/ ID - ref38 ER -